Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Temedica logo — Best for patients. Smart for healthcare.

Temedica

Best for patients. Smart for healthcare.

Founded 2016 Germany Germany 66 employees Series B Total: $42.00M Biotechnology

General Information

Company Name Temedica
Founded Year 2016
Location Germany Germany
Employees 66
Industries Biotechnology
Funding Stage Series B
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Project Based, Tiered Pricing
Hiring 1 role posted in the month to 24 Oct 2026
Offices as of Oct 2026
‏Munich‏، ‏Bavaria‏ ‏80335‏، ‏DE‏, ‏Munich‏، ‏Bavaria‏ ‏80335‏، ‏DE‏
Social

BounceWatch is an independent company data service, not affiliated with Temedica. To contact Temedica, visit temedica.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Temedica compare?

A PDF of Temedica and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Temedica soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Actively Hiring Oct 19, 2026

Hiring for 1 position in the last 30 days.

Get alerts when Temedica shows new signals

About Temedica

Temedica, headquartered in Germany, is a prominent player in the pharma technology sector since its inception in 2016. Positioned as the "commercialization partner you love to work with," Temedica delivers cutting-edge, AI-driven solutions and services tailored for the pharma industry.

The company specializes in leveraging real-world insights and configurable, AI-powered solutions to empower pharma companies, enhancing their brand performance through strategic planning and execution. With its deep medical and commercial expertise, Temedica addresses challenges in pharma's go-to-market strategies, translating them into measurable successes.

Recently, in a significant growth milestone, Temedica secured a €25.00M Series B investment on 01 November 2022 from MIG Capital. This funding underscores investor confidence in its innovative approach and its potential to drive substantial value in the pharma sector.

Business keywords: AI-powered solutions, pharma industry solutions, real-world insights, patient journey data, personalized medicine, individualized medicine, Real-World Evidence, SaaS dashboard, health data analysis, digital healthcare, health insights, treatment adherence, biotech industry services, omnichannel engagement, medical expertise

Services & Products

Permea Insight Hub
Omnichannel Engagement Suite
Market Insights & Analysis
Competitive Benchmarking
Launch Excellence
Brand Strategy & Management
Stakeholder Engagement
Patient Journey Analysis

Target Customers

pharmaceutical companies medical teams marketing teams sales teams patient engagement teams business intelligence teams

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B €25.00M 1
MIG Capital
MIG Capital
01 Nov 2022
Series A €17.00M 4
MIG Capital
MIG Capital, G+J Ventures +2
01 Jan 2020

Temedica Alternatives & Competitors

View All Alternatives
Temedica vs
XO Life
XO Life Germany

Building brite™, the patient-pharma platform turning therapy support into real-world evidence 🌎

38 employees
Biotechnology, Pharmaceutical
Compare Temedica vs XO Life
Temedica vs
RegenMed Circles
RegenMed Circles United States

Clinical, scientific, and financial value through real-world evidence. Supporting providers, industr...

19 employees
Biotechnology
Compare Temedica vs RegenMed Circles
Temedica vs
ODAIA
ODAIA Canada

AI-Powered Pharma Solutions: Maximize commercial impact with ODAIA.

Series B
110 employees
AI, Biotechnology
View all alternatives

FAQ About Temedica

Best for patients. Smart for healthcare.
Temedica was founded in 2016.
Temedica is headquartered in Germany. As of Oct 2026, it also has offices in ‏Munich‏، ‏Bavaria‏ ‏80335‏، ‏DE‏, ‏Munich‏، ‏Bavaria‏ ‏80335‏، ‏DE‏.
Temedica operates in Biotechnology. Its work centres on AI-powered solutions, pharma industry solutions, real-world insights and patient journey data. Its customers include pharmaceutical companies, medical teams and marketing teams.
Temedica has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Project Based and Tiered Pricing.
Temedica has approximately 66 employees.
Temedica has completed 2 funding rounds, raising a total of $42.00M. The latest funding stage is Series B.
Temedica offers: Permea Insight Hub, Omnichannel Engagement Suite, Market Insights & Analysis, Competitive Benchmarking, Launch Excellence, Brand Strategy & Management, Stakeholder Engagement, Patient Journey Analysis, Real-World Evidence Generation, Medical Communication.
Top alternatives and competitors to Temedica include XO Life, RegenMed Circles, ODAIA, National Pharmaceutical Council, Verana Health. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Temedica and XO Life are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Temedica, https://bouncewatch.com/company/temedica, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes